Wednesday, May 25, 2016
Viva Pictures Acquires U.S. Rights to the Morbido Brand
Viva Pictures recently released information that they've landed the U.S. rights to the famed Morbido brand from Mexico. It has become the most important horror and fantasy film festival in Mexico.
The first film to be released under this label will be "The Ouija Summoning" this fall. It will also include original Viva Pictures productions Charlie Charlie and Effigy.
For more information on Viva Pictures, you can goto: http://www.vivafilmco.com
Press Release:
VIVA Pictures announced today that it has landed the U.S. rights to the famed Mórbido brand. Mórbido is a lifestyle horror and fantasy brand which originated in Mexico in 2007. During that time, Mórbido has become the most important festival of the genre in Latin America and has become known as the “voice of horror” in the region with its many platforms that include an FM radio show, a podcast, a publishing house, a distribution label and more. Plans are to initially launch a Mórbido branded movie label through VIVA Pictures which will roll out this fall with The Ouija Summoning as well as the VIVA original productions Charlie Charlie and Effigy. The deal was jointly announced at Cannes by Mórbido’s CEO Pablo Guisa Koestinger and VIVA Pictures President Victor Elizalde.
“We’re extremely excited by the myriad of opportunities that exist with the Mórbido brand and lifestyle,” commented Elizalde. “Horror and sci-fi fans are typically the most loyal followers of any type of genre. The audiences behind the platforms that Pablo has created are indicative of this fact and we look forward to expanding Mórbido’s presence into the U.S. and Canada.”
“It is wonderful to see Mórbido expanding globally,” stated Pablo Guisa Koestinger. “As the creator of the brand as well as being a fan myself, I am looking forward to seeing this partnership truly grow. Mórbido has become a reference in horror as well as a lifestyle and we are happy to be sharing it with the U.S.”
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment